Macawadib, Esnairah G.

HRN: 13-01-25  Sex: Female

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
04/25/2026
PIPERACILLIN + TAZOBACTAM 2.25G (VIAL)
04/25/2026
05/02/2026
IV
2.25g
Q8hrs
UTI
Checking Initial Appropriateness 

 Indication:  Empirical Escalation    Type of Infection:  Urinary Tract    Compliance to guidelines: Compliant To Guidelines